Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-21-010701

Chief Commercial Officer sold 40,000 shares at an average $31.45 ($1,258,099)

  • Chief Commercial Officer acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-05 Exercise or conversion : show line 1 in the form +14,548 $0.39 $5,674 60,624 D
2021-03-05 Exercise or conversion : show line 2 in the form +5,452 $0.28 $1,527 66,076 D
2021-03-05 Sale : show line 3 in the form −5,783 $30.45 $176,092 60,293 D
2021-03-05 Sale : show line 4 in the form −14,217 $31.09 $442,007 46,076 D
2021-03-08 Exercise or conversion : show line 5 in the form +20,000 $0.28 $5,600 66,076 D
2021-03-08 Sale : show line 6 in the form −20,000 $32.00 $640,000 46,076 D
Open-market sales · 40,000 sh · avg $31.45 · $1,258,099

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-05 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −14,548 $0.39 2021-09-27 14,548 0 D
2021-03-05 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −5,452 $0.28 2023-05-29 5,452 52,177 D
2021-03-08 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −20,000 $0.28 2023-05-29 20,000 32,177 D
Loading xslF345X03/doc4.xml…